1. Home
  2. TREX vs ACAD Comparison

TREX vs ACAD Comparison

Compare TREX & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trex Company Inc.

TREX

Trex Company Inc.

HOLD

Current Price

$36.00

Market Cap

3.9B

Sector

N/A

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$20.71

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREX
ACAD
Founded
1996
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.9B
IPO Year
1998
2000

Fundamental Metrics

Financial Performance
Metric
TREX
ACAD
Price
$36.00
$20.71
Analyst Decision
Buy
Buy
Analyst Count
19
22
Target Price
$52.64
$30.45
AVG Volume (30 Days)
2.0M
1.8M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.12
EPS
1.78
2.30
Revenue
$1,174,267,000.00
$726,437,000.00
Revenue This Year
$5.09
$18.52
Revenue Next Year
$6.16
$11.34
P/E Ratio
$20.70
$9.01
Revenue Growth
1.98
40.45
52 Week Low
$29.77
$14.08
52 Week High
$68.78
$28.35

Technical Indicators

Market Signals
Indicator
TREX
ACAD
Relative Strength Index (RSI) 29.26 36.93
Support Level $34.36 $20.45
Resistance Level $35.87 $22.75
Average True Range (ATR) 1.36 0.82
MACD -0.23 -0.11
Stochastic Oscillator 2.22 23.25

Price Performance

Historical Comparison
TREX
ACAD

About TREX Trex Company Inc.

Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: